Jazz Pharmaceuticals
JAZZ
JAZZ
474 hedge funds and large institutions have $6.42B invested in Jazz Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 76 funds opening new positions, 162 increasing their positions, 158 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.26% more ownership
Funds ownership: 91.17% → 93.42% (+2.3%)
5% more capital invested
Capital invested by funds: $6.14B → $6.42B (+$284M)
3% more repeat investments, than reductions
Existing positions increased: 162 | Existing positions reduced: 158
Holders
474
Holding in Top 10
9
Calls
$28.9M
Puts
$15.9M
Top Buyers
| 1 | +$77.2M | |
| 2 | +$74.1M | |
| 3 | +$54.8M | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$32.5M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$31M |
Top Sellers
| 1 | -$136M | |
| 2 | -$66.8M | |
| 3 | -$65.8M | |
| 4 |
BlackRock
New York
|
-$30.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$24M |